Nyxoah (NYXH) Revenue Growth (1y) (2022 - 2026)
Nyxoah (NYXH) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 18.54% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 5.22% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 10.66% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 10.81% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 13.80% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -3.04% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 7.90% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 6.21% |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | 566.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 566.54% |
| Dec 31, 2025 | 395.02% |
| Sep 30, 2025 | 65.81% |
| Jun 30, 2025 | 82.69% |
| Mar 31, 2025 | -15.62% |
| Dec 31, 2024 | 67,527.30% |
| Sep 30, 2024 | 30.86% |
| Jun 30, 2024 | -31.12% |
| Mar 31, 2024 | 280,129.27% |
| Dec 31, 2023 | -100.00% |
| Sep 30, 2023 | 478.98% |
| Jun 30, 2023 | 20.69% |
| Mar 31, 2023 | -99.94% |
| Dec 31, 2022 | 395,133,587.06% |
| Sep 30, 2022 | -23.35% |
| Jun 30, 2022 | 348.30% |